# Immunogenicity of Fractional Dose of the HPV Vaccines

> **NCT05291871** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Washington** · enrollment: 92 (actual)

## Conditions studied

- HPV Infection
- HPV Vaccine

## Interventions

- **BIOLOGICAL:** HPV vaccine

## Key facts

- **NCT ID:** NCT05291871
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291871, "Immunogenicity of Fractional Dose of the HPV Vaccines". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05291871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*